US 7338961
Sphingosine kinase inhibitors
granted A61PA61P1/00A61P1/02
Quick answer
US patent 7338961 (Sphingosine kinase inhibitors) held by Apogee Biotechnology Corporation expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apogee Biotechnology Corporation
- Grant date
- Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00